1
In addition, certain anti-alpha IIb beta 3 LIBS Fab fragments stimulated platelet aggregation.
2
Fab fragments of the parental antibody were prepared by papain digestion.
3
Fab fragments were fused to the carboxyl-terminal domain of the gene III protein.
4
Anti-CTLA-4 antibodies and Fab fragments augmented T cell proliferation in an allogeneic MLR.
5
However, limitations became obvious especially when secreting heterodimeric Fab fragments.
6
In therapy studies using radiometal-conjugated Fab fragments, the kidney is the first dose-limiting organ.
7
Theoretically, the remaining Fab fragments can block pathogen receptors or toxins and still provide protection.
8
Fab fragments of the antibody inhibited platelet aggregation.
9
With these methods, a large, high-quality library with more than 10 billion functional Fab fragments was achieved.
10
Fab fragments produced from IgM and IgG fractions of the MS patients displayed the same amylolytic activity.
11
Internalization of anti-recoverin antibody or its Fab fragments by retinal cells mediated by endocytosis lead to cytotoxicity.
12
The system allows rapid and easy identification of monoclonal Fab fragments in a form suitable for genetic manipulation.
13
The neutralization efficiency of different IgGs varied and Fab fragments derived from these antibodies were generally poorly neutralizing.
14
Also, the soluble scFab preparations exhibited binding and neutralization profiles comparable to that of the corresponding Fab fragments.
15
Administration of cationic amino acids results in a substantial increase in the maximum tolerated dose of such Fab fragments.
16
It was possible to generate, in 2 weeks, large numbers of monoclonal Fab fragments against a transition state analog hapten.
